International › Denmark · Last reviewed 2026-05-16
Denmark
Summary
Adolescent gender care in Denmark is centralised at Rigshospitalet in Copenhagen. The Danish health authority (Sundhedsstyrelsen) revised the national guideline in 2024 and introduced stricter diagnostic requirements for starting GnRHa or cross-sex hormones, acknowledging the experimental status of medical interventions in minors.
1. Clinical organisation
Adolescent gender care in Denmark has been centralised at Rigshospitalet (Sexologisk Klinik), Copenhagen, since 2016. Referrals go via the general practitioner and child psychiatrist.
2. Sundhedsstyrelsen guideline 2024
The Danish health authority published a revised guideline in 2024 that included:
- Extended observation period (at least 12 months) before hormone treatment — stricter application of inclusion criteria.
- Mandatory assessment of psychiatric comorbidity, autism and trauma — see exclusion criteria.
- Acknowledgement of the experimental character of GnRHa in minors.
See also
- Comparable national policy changes: Sweden, Finland, Norway
- Supporting HTA reports: SBU, Cass Review
- Worldwide overview: Status 2025
- International comparison — Denmark alongside other countries in table.
- Timeline — policy decisions chronologically.
- FAQ · Glossary.